{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:54Z","timestamp":1792788054070,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01NS084974"],"award-info":[{"award-number":["P01NS084974"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01NS084974"],"award-info":[{"award-number":["P01NS084974"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01NS084974"],"award-info":[{"award-number":["P01NS084974"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01NS084974"],"award-info":[{"award-number":["P01NS084974"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01NS084974"],"award-info":[{"award-number":["P01NS084974"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01NS084974"],"award-info":[{"award-number":["P01NS084974"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01NS084974"],"award-info":[{"award-number":["P01NS084974"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01NS084974"],"award-info":[{"award-number":["P01NS084974"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Aging","award":["P30AG066511"],"award-info":[{"award-number":["P30AG066511"]}]},{"name":"National Institute of Aging","award":["P30AG066511"],"award-info":[{"award-number":["P30AG066511"]}]},{"name":"National Institute of Aging","award":["P30AG066511"],"award-info":[{"award-number":["P30AG066511"]}]},{"name":"National Institute of Aging","award":["P30AG066511"],"award-info":[{"award-number":["P30AG066511"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG070937"],"award-info":[{"award-number":["AG070937"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG070937"],"award-info":[{"award-number":["AG070937"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS138499."],"award-info":[{"award-number":["R01 NS138499."]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS097816"],"award-info":[{"award-number":["NS097816"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1RO1NS137434"],"award-info":[{"award-number":["1RO1NS137434"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["RF-2021-12374238"],"award-info":[{"award-number":["RF-2021-12374238"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Italian Ministry of Education and Research","award":["No Grant ID"],"award-info":[{"award-number":["No Grant ID"]}]},{"name":"Biogen, Inc","award":["No Grant ID"],"award-info":[{"award-number":["No Grant ID"]}]},{"name":"Biogen, Inc","award":["No Grant ID"],"award-info":[{"award-number":["No Grant ID"]}]},{"name":"Biogen, Inc","award":["No Grant ID"],"award-info":[{"award-number":["No Grant ID"]}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["No grant ID"],"award-info":[{"award-number":["No grant ID"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["No grant ID"],"award-info":[{"award-number":["No grant ID"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Association of Frototemporal Dementia","award":["No grant ID"],"award-info":[{"award-number":["No grant ID"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease involving loss of motor neurons, typically results in death within 3\u20135\u00a0years of disease onset. Although roughly 10% of cases can be linked to a specific inherited mutation (e.g., C9orf72 hexanucleotide repeat expansion or SOD1 mutation), the cause(s) of most cases are unknown. Consequently, there is a critical need for biomarkers that reflect disease onset and progression across ALS subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We employed tandem mass tag mass spectrometry (TMT-MS) based proteomics on cerebrospinal fluid (CSF) to identify and quantify 2105 proteins from sporadic, C9orf72, and SOD1 ALS patients, asymptomatic C9orf72 expansion carriers, and controls (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009101). To verify trends in our Emory University cohort we used data-independent acquisition (DIA-MS) on an expanded, four center cohort. This expanded cohort of 259 individuals included 50 sporadic ALS (sALS), 43 C9orf72 ALS, 22 SOD1 ALS, 72 asymptomatic gene carriers (59 C9orf72 and 13 SOD1) and 72 age-matched controls. We identified 2330 proteins and used differential protein abundance and network analyses to determine how protein profiles vary across disease subtypes in ALS CSF.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Differential abundance and co-expression network analysis identified proteomic differences between ALS and control, as well as differentially abundant proteins between sporadic, C9orf72 and SOD1 ALS. A panel of proteins differentiated forms of ALS that are indistinguishable in a clinical setting. An additional panel differentiated asymptomatic from symptomatic C9orf72 and SOD1 mutation carriers, marking a pre-symptomatic proteomic signature of genetic forms of ALS. Leveraging this large, multicenter cohort, we validated our ALS CSF network and identified ALS-specific proteins and network modules.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study represents a comprehensive analysis of the CSF proteome across sporadic and genetic causes of ALS that resolves differences among these ALS subgroups and also identifies proteins that distinguish symptomatic from asymptomatic gene carriers. These new data point to varying pathogenic pathways that result in an otherwise clinically indistinguishable disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-025-00838-9","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T07:13:03Z","timestamp":1747293183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis"],"prefix":"10.1186","volume":"20","author":[{"given":"Adam N.","family":"Trautwig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Dammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anantharaman","family":"Shantaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc M.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seneshaw","family":"Asress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Lah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Doretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Ticozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy V.","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Garret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor V.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina N.","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary T.","family":"McEachin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas T.","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"issue":"2","key":"838_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162\u201372.","journal-title":"N Engl J Med"},{"issue":"1","key":"838_CR2","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3(1):17071.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"838_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M Dejesus-Hernandez","year":"2011","unstructured":"Dejesus-Hernandez M, Mackenzie RI, Bradley BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-Linked FTD and ALS. Neuron. 2011;72(2):245\u201356.","journal-title":"Neuron"},{"issue":"2","key":"838_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A, Sim\u00f3n-S\u00e1nchez J, Rollinson S, Gibbs RJ, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72(2):257\u201368.","journal-title":"Neuron"},{"issue":"6415","key":"838_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415):59\u201362.","journal-title":"Nature"},{"issue":"1","key":"838_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.15252\/emmm.201708202","volume":"10","author":"ME Umoh","year":"2018","unstructured":"Umoh ME, Dammer EB, Dai J, Duong DM, Lah JJ, Levey AI, et al. A proteomic network approach across the ALS\u2010FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol Med. 2018;10(1):48\u201362.","journal-title":"EMBO Mol Med"},{"issue":"5","key":"838_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020;26(5):769\u201380.","journal-title":"Nat Med"},{"key":"838_CR8","doi-asserted-by":"publisher","first-page":"642324","DOI":"10.3389\/fnins.2021.642324","volume":"15","author":"AG Thompson","year":"2021","unstructured":"Thompson AG, Gray E, Charles PD, Hu MTM, Talbot K, Fischer R, et al. Network analysis of the CSF proteome characterizes convergent pathways of cellular dysfunction in ALS. Front Neurosci. 2021;15:642324.","journal-title":"Front Neurosci"},{"issue":"1","key":"838_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41593-022-01205-3","volume":"26","author":"J Humphrey","year":"2023","unstructured":"Humphrey J, Venkatesh S, Hasan R, Herb JT, De Paiva LK, K\u00fc\u00e7\u00fckali F, et al. Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes. Nat Neurosci. 2023;26(1):150\u201362.","journal-title":"Nat Neurosci"},{"issue":"11","key":"838_CR10","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/acn3.51890","volume":"10","author":"L Vu","year":"2023","unstructured":"Vu L, Garcia-Mansfield K, Pompeiano A, An J, David-Dirgo V, Sharma R, et al. Proteomics and mathematical modeling of longitudinal <scp>CSF<\/scp> differentiates fast versus slow <scp>ALS<\/scp> progression. Ann Clin Transl Neurol. 2023;10(11):2025\u201342.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"838_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41386-020-00840-3","volume":"46","author":"S Rayaprolu","year":"2021","unstructured":"Rayaprolu S, Higginbotham L, Bagchi P, Watson CM, Zhang T, Levey AI, et al. Systems-based proteomics to resolve the biology of Alzheimer\u2019s disease beyond amyloid and tau. Neuropsychopharmacology. 2021;46(1):98\u2013115.","journal-title":"Neuropsychopharmacology"},{"issue":"43","key":"838_CR12","doi-asserted-by":"publisher","first-page":"eaaz9360","DOI":"10.1126\/sciadv.aaz9360","volume":"6","author":"L Higginbotham","year":"2020","unstructured":"Higginbotham L, Ping L, Dammer EB, Duong DM, Zhou M, Gearing M, et al. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer\u2019s disease. Sci Adv. 2020;6(43):eaaz9360.","journal-title":"Sci Adv"},{"issue":"1","key":"838_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","volume":"14","author":"EB Dammer","year":"2022","unstructured":"Dammer EB, Ping L, Duong DM, Modeste ES, Seyfried NT, Lah JJ, et al. Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimer\u2019s Res Ther. 2022;14(1):174.","journal-title":"Alzheimer's Res Ther."},{"issue":"1","key":"838_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13024-023-00638-z","volume":"18","author":"ES Modeste","year":"2023","unstructured":"Modeste ES, Ping L, Watson CM, Duong DM, Dammer EB, Johnson ECB, et al. Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer\u2019s disease. Mol Neurodegen. 2023;18(1):48.","journal-title":"Mol Neurodegen"},{"key":"838_CR15","doi-asserted-by":"publisher","first-page":"8170759","DOI":"10.1155\/2019\/8170759","volume":"2019","author":"A Winiarska","year":"2019","unstructured":"Winiarska A, Zareba L, Krolczyk G, Czyzewicz G, Zabczyk M, Undas A. Decreased levels of histidine-rich glycoprotein in advanced lung cancer: association with prothrombotic alterations. Dis Markers. 2019;2019:8170759.","journal-title":"Dis Markers"},{"issue":"1","key":"838_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.36","volume":"5","author":"L Ping","year":"2018","unstructured":"Ping L, Duong DM, Yin L, Gearing M, Lah JJ, Levey AI, et al. Global quantitative analysis of the human brain proteome in Alzheimer\u2019s and Parkinson\u2019s Disease. Scient Data. 2018;5(1): 180036.","journal-title":"Scient Data"},{"issue":"4","key":"838_CR17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","volume":"86","author":"J Magistretti","year":"2015","unstructured":"Magistretti J, Allaman PI. A cellular perspective on brain energy metabolism and functional imaging. Neuron. 2015;86(4):883\u2013901.","journal-title":"Neuron"},{"issue":"11","key":"838_CR18","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/bioinformatics\/btu075","volume":"30","author":"M Maienschein-Cline","year":"2014","unstructured":"Maienschein-Cline M, Lei Z, Gardeux V, Abbasi T, Machado RF, Gordeuk V, et al. ARTS: automated randomization of multiple traits for study design. Bioinformatics. 2014;30(11):1637\u20139.","journal-title":"Bioinformatics"},{"issue":"5","key":"838_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nmeth.4256","volume":"14","author":"AT Kong","year":"2017","unstructured":"Kong AT, Leprevost FV, Avtonomov DM, Mellacheruvu D, Nesvizhskii AI. MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry\u2013based proteomics. Nat Methods. 2017;14(5):513\u201320.","journal-title":"Nat Methods"},{"issue":"9","key":"838_CR20","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1074\/mcp.TIR120.002048","volume":"19","author":"F Yu","year":"2020","unstructured":"Yu F, Haynes SE, Teo GC, Avtonomov DM, Polasky DA, Nesvizhskii AI. Fast quantitative analysis of timsTOF PASEF data with MSFragger and IonQuant. Mol Cell Proteo. 2020;19(9):1575\u201385.","journal-title":"Mol Cell Proteo"},{"issue":"1","key":"838_CR21","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1038\/s41467-023-40129-9","volume":"14","author":"KL Yang","year":"2023","unstructured":"Yang KL, Yu F, Teo GC, Li K, Demichev V, Ralser M, et al. MSBooster: improving peptide identification rates using deep learning-based features. Nat Commun. 2023;14(1):4539.","journal-title":"Nat Commun"},{"issue":"11","key":"838_CR22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nmeth1113","volume":"4","author":"L K\u00e4ll","year":"2007","unstructured":"K\u00e4ll L, Canterbury JD, Weston J, Noble WS, Maccoss MJ. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods. 2007;4(11):923\u20135.","journal-title":"Nat Methods"},{"key":"838_CR23","doi-asserted-by":"crossref","unstructured":"Guo Q, Ping L, Dammer EB, et al. Heparin-enriched plasma proteome is significantly altered in Alzheimer\u2019s disease. Mol Neurodegeneration. 2024;19(1):67.","DOI":"10.1186\/s13024-024-00757-1"},{"issue":"5","key":"838_CR24","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1074\/mcp.M114.044305","volume":"14","author":"R Bruderer","year":"2015","unstructured":"Bruderer R, Bernhardt OM, Gandhi T, Miladinovi\u0107 SM, Cheng L-Y, Messner S, et al. Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Mol Cell Prot. 2015;14(5):1400\u201310.","journal-title":"Mol Cell Prot"},{"key":"838_CR25","doi-asserted-by":"publisher","first-page":"1092341","DOI":"10.3389\/fsysb.2023.1092341","volume":"3","author":"EB Dammer","year":"2023","unstructured":"Dammer EB, Seyfried NT, Johnson ECB. Batch correction and harmonization of \u2013Omics datasets with a tunable median polish of ratio. Front Syst Biol. 2023;3:1092341.","journal-title":"Front Syst Biol."},{"key":"838_CR26","doi-asserted-by":"publisher","first-page":"106286","DOI":"10.1016\/j.nbd.2023.106286","volume":"186","author":"L Higginbotham","year":"2023","unstructured":"Higginbotham L, Carter KE, Dammer BE, Haque UR, Johnson CBE, Duong MD, et al. Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairment. Neurobiol Dis. 2023;186:106286.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"838_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson ECB, Carter EK, Dammer EB, Duong DM, Gerasimov ES, Liu Y, et al. Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci. 2022;25(2):213\u201325.","journal-title":"Nat Neurosci"},{"key":"838_CR28","unstructured":"Calaway R, Corporation M, Weston S, Tenenbaum D. Package \u2018doParallel'. 1.0.14 ed. CRAN2018. p. Provides a parallel backend for the %dopar% function using the parallel package."},{"key":"838_CR29","unstructured":"Wickham H, Chang W, Henry L, Takahashi K, Wilke C, Woo K, et al. Package \u2018ggplot2\u2019. Create elegant data visualisations using the grammar of graphics. 2 ed. CRAN2016."},{"issue":"1","key":"838_CR30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9(1):559.","journal-title":"BMC Bioinform"},{"key":"838_CR31","unstructured":"Kaufman L, Rousseeuw PJ. Finding groups in data : an introduction to cluster analysis. Hoboken, N.J.: Wiley; 2005. xiv, 342 p. p."},{"issue":"2","key":"838_CR32","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","volume":"14","author":"J Reimand","year":"2019","unstructured":"Reimand J, Isserlin R, Voisin V, Kucera M, Tannus-Lopes C, Rostamianfar A, et al. Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA Cytoscape and EnrichmentMap. Nat Prot. 2019;14(2):482\u2013517.","journal-title":"Nat Prot"},{"issue":"1","key":"838_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","volume":"4","author":"NT Seyfried","year":"2017","unstructured":"Seyfried NT, Dammer EB, Swarup V, Nandakumar D, Duong DM, Yin L, et al. A Multi-network Approach identifies protein-specific Co-expression in asymptomatic and symptomatic alzheimer\u2019s disease. Cell Syst. 2017;4(1):60\u201372.e4.","journal-title":"Cell Syst"},{"issue":"1","key":"838_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ana.24552","volume":"79","author":"P Weydt","year":"2016","unstructured":"Weydt P, Oeckl P, Huss A, M\u00fcller K, Volk AE, Kuhle J, et al. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis. Ann Neurol. 2016;79(1):152\u20138.","journal-title":"Ann Neurol"},{"issue":"1","key":"838_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","volume":"91","author":"M Bacioglu","year":"2016","unstructured":"Bacioglu M, Maia LF, Preische O, Schelle J, Apel A, Kaeser SA, et al. Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases. Neuron. 2016;91(1):56\u201366.","journal-title":"Neuron"},{"issue":"1","key":"838_CR36","first-page":"12","volume":"87","author":"P Steinacker","year":"2016","unstructured":"Steinacker P, Feneberg E, Weishaupt J, Brettschneider J, Tumani H, Andersen PM, et al. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. J Neurol, Neurosurg Psychiatry. 2016;87(1):12\u201320.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"issue":"2","key":"838_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ana.25143","volume":"83","author":"AG Thompson","year":"2018","unstructured":"Thompson AG, Gray E, Th\u00e9z\u00e9nas ML, Charles PD, Evetts S, Hu MT, et al. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis. Ann Neurol. 2018;83(2):258\u201368.","journal-title":"Ann Neurol"},{"issue":"4","key":"838_CR38","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/jnnp-2019-321916","volume":"91","author":"L Vu","year":"2020","unstructured":"Vu L, An J, Kovalik T, Gendron T, Petrucelli L, Bowser R. Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes. J Neurol, Neurosurg Psychiatry. 2020;91(4):350\u20138.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"issue":"2","key":"838_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/jnc.16030","volume":"168","author":"ER Dellar","year":"2024","unstructured":"Dellar ER, Vendrell I, Talbot K, Kessler BM, Fischer R, Turner MR, et al. Data-independent acquisition proteomics of cerebrospinal fluid implicates endoplasmic reticulum and inflammatory mechanisms in amyotrophic lateral sclerosis. J Neurochem. 2024;168(2):115\u201327.","journal-title":"J Neurochem"},{"issue":"2","key":"838_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/jnnp-2016-313521","volume":"88","author":"T Bali","year":"2017","unstructured":"Bali T, Self W, Liu J, Siddique T, Wang LH, Bird TD, et al. Defining SOD1 ALS natural history to guide therapeutic clinical trial design. J Neurol Neurosurg Psychiatry. 2017;88(2):99\u2013105.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"838_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00401-019-02093-x","volume":"139","author":"P Oeckl","year":"2020","unstructured":"Oeckl P, Weydt P, Thal DR, Weishaupt JH, Ludolph AC, Otto M. Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis. Acta Neuropathol. 2020;139(1):119\u201334.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"838_CR42","doi-asserted-by":"publisher","first-page":"16334","DOI":"10.1038\/s41598-018-34642-x","volume":"8","author":"MS Bereman","year":"2018","unstructured":"Bereman MS, Beri J, Enders JR, Nash T. Machine learning reveals protein signatures in CSF and plasma fluids of clinical value for ALS. Scient Rep. 2018;8(1):16334.","journal-title":"Scient Rep."},{"issue":"5","key":"838_CR43","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/biomedicines11051250","volume":"11","author":"S Oh","year":"2023","unstructured":"Oh S, Jang Y, Na CH. Discovery of biomarkers for amyotrophic lateral sclerosis from human cerebrospinal fluid using mass-spectrometry-based proteomics. Biomedicines. 2023;11(5):1250.","journal-title":"Biomedicines"},{"issue":"1","key":"838_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ng.2007.52","volume":"40","author":"MA Van Es","year":"2008","unstructured":"Van Es MA, Van Vught PW, Blauw HM, Franke L, Saris CG, Van Den Bosch L, et al. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat Genet. 2008;40(1):29\u201331.","journal-title":"Nat Genet"},{"issue":"6","key":"838_CR45","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/acn3.51784","volume":"10","author":"CV Ly","year":"2023","unstructured":"Ly CV, Ireland MD, Self WK, Bollinger J, Jockel-Balsarotti J, Herzog H, et al. Protein kinetics of superoxide dismutase-1 in familial and sporadic amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2023;10(6):1012\u201324.","journal-title":"Ann Clin Transl Neurol"},{"issue":"12","key":"838_CR46","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","volume":"387","author":"TM Miller","year":"2022","unstructured":"Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, et al. Trial of antisense oligonucleotide tofersen for <i>SOD1<\/i> ALS. N Engl J Med. 2022;387(12):1099\u2013110.","journal-title":"N Engl J Med"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00838-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00838-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00838-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T08:03:24Z","timestamp":1747296204000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00838-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00838-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.02.29.582840","asserted-by":"object"}]},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Local institutional review boards approved the procedures for this study and written informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"N.T.S, A.I.L and D.M.D. are co-founders and consultants of Emtherapro. D.M.D. and N.T.S are co-founders of Arc Proteomics. N.T.S, Z.T.M and J.D.G are co-founders of StitchRx.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}